Skip to main content
Toggle navigation
Login
Search
Home
Tweets by 2023 SSO Annual Meeting
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Home
Browse by Speaker
Browse by Speaker
Browse by Speaker
Type here to filter the list
All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
R
Radaelli, Stefano
Fondazione IRCCS Istituto Nazionale Tumori
P58: Immune infiltrate of primary retroperitoneal sarcomas (RPS): a prognostic study
Location:SSO HUB: Melanoma & Sarcoma Zone
Stefano Radaelli
P64: Surgical management of the duodenum during multivisceral resection for retroperitoneal sarcoma (RPS)
Location:SSO HUB: Melanoma & Sarcoma Zone
Stefano Radaelli
Radomski, Shannon
Department of Surgery, Johns Hopkins Hospital
28: Tumor Deposits Are Associated with a Higher Risk of Peritoneal Disease in Non-Metastatic Colorectal Cancer Patients
Location:Ballroom C
Shannon Radomski
71: Intra-and interpatient drug response heterogeneity exist in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for gastrointestinal cancers
Location:Ballroom B
Shannon Radomski
Rail, Benjamin
UT Southwestern Medical Center
72: Cost Analysis and Financial Implications of Cytoreductive Surgery and HIPEC: a US Single Center Experience
Location:Ballroom B
Benjamin Rail
P18: Perioperative Outcomes of Robotic and Laparoscopic Surgery for Colorectal Cancer: A Propensity Score Matched Analysis
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Benjamin Rail
Rajput, Maheen
University of Iowa Hospitals and Clinics
42: Machine-learning based investigation of prognostic indicators for oncological outcome of pancreatic ductal adenocarcinoma
Location:Ballroom B
Maheen Rajput
Ramsdale, Erika
University of Rochester Medical Center
85: Impact of Incident Hospital-Acquired Geriatric Syndromes on Short-term Outcomes following Gastrointestinal Cancer Resection
Location:Ballroom B
Erika Ramsdale
P34: Determining Safety and Tolerability of SX-682 in Combination with Anti-PD1 as Maintenance Therapy for Unresectable Pancreatic Adenocarcinoma, A Phase I Study
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Erika Ramsdale
Randhawa, Simran
University of Colorado School of Medicine, Department of Surgery, Division of Cardiothoracic Surgery
P77: Prospective Evaluation of a Universally Applied Laparoscopic Gastric Ischemic Preconditioning Protocol Prior to Esophagectomy with Comparison to Historical Controls
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Simran Randhawa
Raoof, Mustafa
Department of Surgery, Cancer Genetics and Epigenetics
23: Single-cell RNA Sequencing Reveals Distinct Populations of Tumor Associated Macrophages in Colorectal Metastasis.
Location:Ballroom C
Mustafa Raoof
P35: Slow Adoption of Observation for Small Pancreatic Neuroendocrine Tumors
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Mustafa Raoof
P54: A comparative evaluation of efficacy endpoints in colorectal and appendiceal carcinomatosis treated with PIPAC: Secondary analysis of a US multicenter phase 1 trial
Location:SSO HUB: Rare/Metastatic Cancers Zone
Mustafa Raoof
PIPAC
Location:SSO HUB Theater
Mustafa Raoof
Rao, Roshni
Columbia University
P2: Incidence of lymph node involvement in clinically node-negative breast cancer patients following neoadjuvant chemotherapy and identification of clinicopathologic features which may lead to omission of sentinel lymph node biopsy
Location:SSO HUB: Breast & Endocrine Zone
Roshni Rao
Raper, Anna
University of Pennsylvania, Medical Genetics
P25: What are the clinical implications of SDHA pathogenic variants?
Location:SSO HUB: Breast & Endocrine Zone
Anna Raper
Rauch, Gaiane
MD Anderson Cancer Center
7: Multicenter clinical trial for omission of breast surgery in invasive cancer following neoadjuvant systemic therapy: Longitudinal patient reported outcomes and decisional comfort planned analyses
Location:Veterans Memorial Auditorium
Gaiane Rauch
Raut, Chandrajit
Brigham and Women's Hospital Harvard Medical School
Neoadjuvant Chemotherapy for Soft Tissue Sarcomas: A Patient-Centric Approach
Location:Ballroom A
Chandrajit Raut
Reddy, Biren
Department of Surgery, Section of General Surgery and Surgical Oncology, University of Chicago Medical Center
P53: Therapeutic Implications of Germline Testing in Peritoneal Mesothelioma
Location:SSO HUB: Rare/Metastatic Cancers Zone
Biren Reddy
Reeves, Mark
Loma Linda University Health
Global Partner Poster Presentations
Location:Ballroom C
Mark Reeves
Regenbogen, Scott
University of Michigan
26: Neoadjuvant Chemoradiation Does Not Improve Outcomes for Patients Undergoing Resection for Upper Rectal Cancer: A US Rectal Cancer Consortium Analysis
Location:Ballroom C
Scott Regenbogen
Rehman, Shahyan
National Cancer Institute
40: Pre-clinical and clinical evaluation of tivozanib for Exportin 7/Ste20-like-kinase (XPO7/SLK)-expressing cholangiocarcinoma
Location:Ballroom B
Shahyan Rehman
Reilly, Christine
Vaccinex, Inc.
55: Neoadjuvant Pepinemab in Combination with Nivolumab and/or Ipilimumab in Resectable Stage III Melanoma
Location:Veterans Memorial Auditorium
Christine Reilly
Remmert, Kirsten
National Cancer Institute | National Institutes of Health
40: Pre-clinical and clinical evaluation of tivozanib for Exportin 7/Ste20-like-kinase (XPO7/SLK)-expressing cholangiocarcinoma
Location:Ballroom B
Kirsten Remmert
P51: Hyperthermic intraperitoneal chemotherapy restores physiologic tumor stiffness & stimulates lymphocyte proliferation & recruitment
Location:SSO HUB: Rare/Metastatic Cancers Zone
Kirsten Remmert
Ren, Yi
Duke Cancer Institute, Duke University Medical Center, Durham, NC
P10: High Risk Screening in Women with BRCA1/2 Mutations Age 70 and Above
Location:SSO HUB: Breast & Endocrine Zone
Yi Ren
P6: Short-term outcomes in DCIS patients managed without initial surgery
Location:SSO HUB: Breast & Endocrine Zone
Yi Ren
Reyes, Arith Ruth
Columbia University Medical Center
P2: Incidence of lymph node involvement in clinically node-negative breast cancer patients following neoadjuvant chemotherapy and identification of clinicopathologic features which may lead to omission of sentinel lymph node biopsy
Location:SSO HUB: Breast & Endocrine Zone
Arith Ruth Reyes
Reymond, Marc
University of Tuebingen
P54: A comparative evaluation of efficacy endpoints in colorectal and appendiceal carcinomatosis treated with PIPAC: Secondary analysis of a US multicenter phase 1 trial
Location:SSO HUB: Rare/Metastatic Cancers Zone
Marc Reymond
Reyna, Chantal
Crozer Health System
Breast Parallel Session 2
Location:Veterans Memorial Auditorium
Chantal Reyna
Elucent Industry Spotlight Session: Software Based Surgical Navigation and the Clinical Advantages
Location:SSO HUB Theater
Chantal Reyna
Rhodes, Terence Duane
Intermountain Medical Center
60: Safety, efficacy, and biomarker assessment of RP1 in combination with nivolumab in patients with advanced skin cancers
Location:Veterans Memorial Auditorium
Terence Duane Rhodes
Rhodin, Kristen
Duke University Medical Center
52: Adjuvant chemotherapy for resected intrahepatic cholangiocarcinoma confers no survival advantage.
Location:Ballroom A
Kristen Rhodin
58: Timing of Adjuvant Immunotherapy in Stage III Melanoma, Does it Matter?
Location:Veterans Memorial Auditorium
Kristen Rhodin
P41: A Multi-Institution Observational Analysis of the Theory of the Immunization Effect in Patients with Multiple Primary Melanomas
Location:SSO HUB: Melanoma & Sarcoma Zone
Kristen Rhodin
P60: Evolution in management of upfront treatment for desmoid tumors
Location:SSO HUB: Melanoma & Sarcoma Zone
Kristen Rhodin
P79: Impact of Tumor Size and Management on Survival in Gastric GIST
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Kristen Rhodin
Ribas, Antoni
University of California Los Angeles, Los Angeles, CA, USA
53: Surgical Outcomes of SWOG1801: Neoadjuvant/adjuvant versus adjuvant pembrolizumab for resectable stage III-IV melanoma
Location:Veterans Memorial Auditorium
Antoni Ribas
57: Neoadjuvant Pembrolizumab in Stage II-III Desmoplastic Melanoma (SWOG S1512): Surgical Considerations
Location:Veterans Memorial Auditorium
Antoni Ribas
Ribeiro, Heber
AC Camargo Cancer Center
Between Patient and Policy Maker - What We Can do to Build Global Capacity for Cancer Surgery
Location:Ballroom A
Heber Ribeiro
Ricker, Ansley
Atrium Health Carolinas Medical Center
47: Surgical Microwave Ablation for Treatment of Hepatocellular Carcinoma: A Single Institution Review from 2006-2022
Location:Ballroom A
Ansley Ricker
Riedel, Richard
Duke Univesity Medical Center
11: Genomic Landscape of Malignant Phyllodes Tumors Reveals Multiple Targetable Opportunities
Location:Veterans Memorial Auditorium
Richard Riedel
P60: Evolution in management of upfront treatment for desmoid tumors
Location:SSO HUB: Melanoma & Sarcoma Zone
Richard Riedel
Robbins, Keenan
Washington University School of Medicine
37: Hepatic Artery Infusion Chemotherapy Compared to Y90 for Treatment of Unresectable Colorectal Liver Metastases: A Multi-Institutional Comparative Study
Location:Ballroom B
Keenan Robbins
Robey, Robert
National Cancer Institute, Laboratory of Cell Biology
P30: Validating a Genome-wide CRISPR Screen Determining Mechanisms of Drug Resistance in Pancreatic Adenocarcinoma
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Robert Robey
Robinson, Christina
Laboratory Animal Sciences Program, National Cancer Institute
40: Pre-clinical and clinical evaluation of tivozanib for Exportin 7/Ste20-like-kinase (XPO7/SLK)-expressing cholangiocarcinoma
Location:Ballroom B
Christina Robinson
Rodriguez Franco, Salvador
Department of Surgery, University of Colorado Anschutz Medical Campus
P19: Pathological Features Associated With Lymph Node Disease in Patients with Appendiceal Neuroendocrine Tumors.
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Salvador Rodriguez Franco
Rodriguez-Quintero, Jorge Humberto
Montefiore Medical Center/ Albert Einstein College of Medicine
P14: ART1, a mono-ADP-ribosyl transferase, is increased by chemotherapy and radiotherapy and is a novel target in colorectal carcinoma.
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Jorge Humberto Rodriguez-Quintero
Roland, Christina
The University of Texas MD Anderson Cancer Center
Case Presentation and Discussion
Location:Ballroom A
Christina Roland
Ronnekleiv-Kelly, Sean
University of Wisconsin School of Medicine and Public Health
43: Optimal Duration of Chemotherapy in the Era of Neoadjuvant Therapy for Pancreatic Adenocarcinoma - Is There a Magic Number?
Location:Ballroom B
Sean Ronnekleiv-Kelly
Rooney, Marguerite
Duke University Hospital
P10: High Risk Screening in Women with BRCA1/2 Mutations Age 70 and Above
Location:SSO HUB: Breast & Endocrine Zone
Marguerite Rooney
Rose, Johnie
Dept of Population and Quantitative Health Sciences
98: Disparities in Receipt of Complex GI Cancer Surgery at a Small Geographic Scale
Location:Ballroom A
Johnie Rose
Rosemurgy, Alexander
Digestive Health Institute Tampa
101: Robotic Transhiatal Esophagectomy
Location:Veterans Memorial Auditorium
Alexander Rosemurgy
99: Technique of IVC Resection and Replacement During Liver Resection
Location:Veterans Memorial Auditorium
Alexander Rosemurgy
Rosenbaum, Evan
Department of Medicine
74: Interim Results of a Phase II Trial of Regional Melphalan via Limb Infusion and Systemic PD1 Blockade in Patients with Extremity Sarcoma
Location:Veterans Memorial Auditorium
Evan Rosenbaum
Rosenberger, Laura
Duke University Medical Center
11: Genomic Landscape of Malignant Phyllodes Tumors Reveals Multiple Targetable Opportunities
Location:Veterans Memorial Auditorium
Laura Rosenberger
4: Germline Genetic Mutations in a Prospective Multi-Center Cohort of 241 Phyllodes Tumors; Time to Expand Testing Criteria
Location:Veterans Memorial Auditorium
Laura Rosenberger
Rosenkrantz Hölmich, Lisbet
Department of Plastic Surgery, Herlev University Hospital, University of Copenhagen
56: International Validation Study of the Melanoma Institute Australia Sentinel Node Metastasis Risk Nomogram
Location:Veterans Memorial Auditorium
Lisbet Rosenkrantz Hölmich
Rosenkranz, Kari
Dartmouth Health
1: Impact of Breast Conservation Therapy on Local Recurrence in Patients with Multiple Ipsilateral Breast Cancer – Results from ACOSOG Z11102 (Alliance)
Location:Veterans Memorial Auditorium
Kari Rosenkranz
Ross, Alistair
Department of Plastic Surgery Guy's and St Thomas' NHS Foundation Trust London, United Kingdom
56: International Validation Study of the Melanoma Institute Australia Sentinel Node Metastasis Risk Nomogram
Location:Veterans Memorial Auditorium
Alistair Ross
Rossi, Alexander
National Cancer Institute
40: Pre-clinical and clinical evaluation of tivozanib for Exportin 7/Ste20-like-kinase (XPO7/SLK)-expressing cholangiocarcinoma
Location:Ballroom B
Alexander Rossi
Rossi, Ferdinando
University of Pennsylvania
75: T cell Inducible Costimulator (ICOS) blockade increases the efficacy of imatinib in Gastrointestinal Stromal Tumor (GIST)
Location:Ballroom A
Ferdinando Rossi
91: CD40 activation has direct tumor effects in gastrointestinal stromal tumor (GIST)
Location:Ballroom A
Ferdinando Rossi
Ross, Jeffrey
Foundation Medicine Inc
11: Genomic Landscape of Malignant Phyllodes Tumors Reveals Multiple Targetable Opportunities
Location:Veterans Memorial Auditorium
Jeffrey Ross
Ross, Merrick
The University of Texas MD Anderson Cancer Center
54: Adjuvant Pembrolizumab in Stage II Melanoma: Outcomes by Tumor Location in the Phase 3 KEYNOTE-716 Study
Location:Veterans Memorial Auditorium
Merrick Ross
Ross, Sharona
Digestive Health Institute Tampa
101: Robotic Transhiatal Esophagectomy
Location:Veterans Memorial Auditorium
Sharona Ross
99: Technique of IVC Resection and Replacement During Liver Resection
Location:Veterans Memorial Auditorium
Sharona Ross
Rothermel, Luke
University Hospitals, Cleveland Medical Center
31: Factors Predicting Immunotherapy Utilization for Metastatic Merkel Cell Carcinoma from 2015-2018
Location:Ballroom A
Luke Rothermel
P69: Understanding Factors Leading to Surgical Attrition for “Resectable” Gastric Cancer
Location:SSO HUB: Rare/Metastatic Cancers Zone
Luke Rothermel
Rubin, Adi
Tel Aviv Sourasky Medical Center, Tel-Aviv, Israel
90: Obesity and Gastric Cancer Aggressiveness – a New Link
Location:Veterans Memorial Auditorium
Adi Rubin
Rubio, Isabel
Clinica Universidad de Navarra, Madrid
Multidisciplinary Management of Cancer Globally
Location:Room 302
Isabel Rubio
Ruel, Christopher
City of Hope National Medical Center
P54: A comparative evaluation of efficacy endpoints in colorectal and appendiceal carcinomatosis treated with PIPAC: Secondary analysis of a US multicenter phase 1 trial
Location:SSO HUB: Rare/Metastatic Cancers Zone
Christopher Ruel
Ruffolo, Luis
University of Rochester Medical Center
38: Semaphorin 4D is Expressed by Activated Lymphocytes in Pancreatic Adenocarcinoma, and Monoclonal Blockade Sensitizes Murine Tumors to Immune Checkpoint Therapy
Location:Ballroom B
Luis Ruffolo
46: Pan-Lysyl Oxidase Inhibition Disrupts Macrophage Invasion and Renders Tumor-Associated Macrophages Susceptible to Cytotoxic Chemotherapy in Cholangiocarcinoma
Location:Ballroom A
Luis Ruffolo
P34: Determining Safety and Tolerability of SX-682 in Combination with Anti-PD1 as Maintenance Therapy for Unresectable Pancreatic Adenocarcinoma, A Phase I Study
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Luis Ruffolo
Ruff, Samantha
The Ohio State University Wexner Medical Center, The James Cancer Hospital and Solove Research Institute
67: Molecular mechanism of colorectal peritoneal metastasis: an interesting TWIST
Location:Ballroom B
Samantha Ruff
P59: Comparing complete compartmental resection with tumor only resection of retroperitoneal soft tissue sarcoma using the win ratio
Location:SSO HUB: Melanoma & Sarcoma Zone
Samantha Ruff
Rusch, Valerie
James Ewing Lecture: “Developing Sustainable Surgical Specialty Programs in East Africa”
Location:Veterans Memorial Auditorium
Valerie Rusch
Russo, Ashley
Cedars-Sinai Medical Center - Los Angeles, CA
32: Impact of Primary Tumor Resection on Metastatic Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors
Location:Ballroom A
Ashley Russo
Ruth, Karen
Fox Chase Cancer Center
14: Should patients with HR+HER2- breast cancer and 1-3 positive sentinel nodes undergo axillary dissection to determine candidacy for abemaciclib?
Location:Veterans Memorial Auditorium
Karen Ruth
P41: A Multi-Institution Observational Analysis of the Theory of the Immunization Effect in Patients with Multiple Primary Melanomas
Location:SSO HUB: Melanoma & Sarcoma Zone
Karen Ruth
Rutkowski, Piotr
Maria Skłodowska-Curie National Research Institute of Oncology
54: Adjuvant Pembrolizumab in Stage II Melanoma: Outcomes by Tumor Location in the Phase 3 KEYNOTE-716 Study
Location:Veterans Memorial Auditorium
Piotr Rutkowski
63: Adjuvant therapy with nivolumab versus placebo in patients with resected stage IIB/C melanoma (CheckMate 76K)
Location:Veterans Memorial Auditorium
Piotr Rutkowski
Ruzzenente, Andrea
Department of Surgery, Dentistry, Gynecology, and Pediatrics, Division of General and Hepato-Biliary Surgery, University of Verona, University Hospital G.B. Rossi, Verona, Italy
34: An Artificial Intelligence Approach to Determining Optimal Margin Width in Patients Undergoing Hepatectomy for Intrahepatic Cholangiocarcinoma
Location:Veterans Memorial Auditorium
Andrea Ruzzenente
Ryan, Andrew
Brown University
P72: Association Of Hospital Network Affiliation with Surgical Outcomes and Spending For Complex Cancer: A longitudinal study of hospital mergers and acquisitions from 2010 to 2018
Location:SSO HUB: Rare/Metastatic Cancers Zone
Andrew Ryan
Ryan, David
Masscahusetts General Hospital
Optimal Neoadjuvant Regimens
Location:Ballroom B
David Ryan
Questions and Discussions
Location:Ballroom B
David Ryan
Ryder, Mabel
Endocrinology, Diabetes, and Metabolism; Department of Endocrinology, Mayo Clinic
P28: Hurthle cell carcinoma - Is a hemithyroidectomy enough?
Location:SSO HUB: Breast & Endocrine Zone
Mabel Ryder
Ryser, Marc
Duke Cancer Institute, Department of Population Health Sciences, Department of Mathematics
P6: Short-term outcomes in DCIS patients managed without initial surgery
Location:SSO HUB: Breast & Endocrine Zone
Marc Ryser
Back to Top
